These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18724429)

  • 41. Reperfusion injury in the lower limb.
    Trudgian J
    Br J Nurs; 2016; 25(20 Suppl 20):S25-S26. PubMed ID: 29480662
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of suppurative-necrotic foot lesions in diabetes mellitus].
    Genyk SN; Batsiurko VI; Karas' GM; Shevchuk VS; Pidufalyĭ VR
    Vestn Khir Im I I Grek; 1988 Apr; 140(4):52-5. PubMed ID: 3420751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study--the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study.
    Mannucci E; Genovese S; Monami M; Navalesi G; Dotta F; Anichini R; Romagnoli F; Gensini G
    Acta Diabetol; 2014; 51(3):435-40. PubMed ID: 24352342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Estimation of efficacy of the ozone-quant therapy in prophylaxis and treatment of the purulent-necrotic complications of pancreatic pseudocysts].
    Hazdiuk PV
    Klin Khir; 2009; (11-12):101-5. PubMed ID: 20458954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of new generation application sorbents on the results of complex treatment in patients with diabetic foot syndrome].
    Biliaieva OO; Neshta VV; Kurylyshyn VP
    Klin Khir; 2009 May; (5):35-7. PubMed ID: 19957747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy.
    Zhang J; Sun XJ; Chen J; Hu ZW; Wang L; Gu DM; Wang AP
    J Diabetes Complications; 2017 Jan; 31(1):241-244. PubMed ID: 27623390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report.
    Mehrannia M; Vaezi M; Yousefshahi F; Rouhipour N
    Can J Diabetes; 2014 Feb; 38(1):5-8. PubMed ID: 24485205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Factor XIII: experimental and clinical results in diabetic foot ulcer].
    Wozniak G; Noll T; Bott U; Hehrlein FW
    Zentralbl Chir; 1999; 124 Suppl 1():73-7. PubMed ID: 10436533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Unusual cause of foot defect in patient with diabetes mellitus].
    Tomešová J; Lacigová S; Cechurová D; Gruberová J; Rušavý Z
    Vnitr Lek; 2012 Nov; 58(11):875-7. PubMed ID: 23256835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Charcot foot: a diagnosis not to ignore].
    Khammassi N; Kort Y
    Pan Afr Med J; 2015; 22():83. PubMed ID: 26848330
    [No Abstract]   [Full Text] [Related]  

  • 52. Diabetic patients with foot burns.
    Dijkstra S; vd Bent MJ; vd Brand HJ; Bakker JJ; Boxma H; Tjong Joe Wai R; Berghout A
    Diabet Med; 1997 Dec; 14(12):1080-3. PubMed ID: 9455938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ozone hemo- and antioxidant therapy and endogenous intoxication in gestosis].
    Ivanchenko SA
    Lik Sprava; 1999; (7-8):130-3. PubMed ID: 10672715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of combined and local cytokine- and ozone therapy on the indices of lipid peroxidation, endogenous intoxication and ferroproteins in diffuse peritonitis].
    Gadzhiev ND; Nasirov MIa; Sushkov SV; Klimova EM
    Vestn Khir Im I I Grek; 2014; 173(2):38-41. PubMed ID: 25055532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The use of antihypoxant therapy for the complex surgical treatment of the gangrene-ischemic diabetic foot syndrome].
    Skripko VD; Del'tsova EI; Gonchar MG; Sabadosh RV
    Khirurgiia (Mosk); 2013; (6):59-64. PubMed ID: 23887264
    [No Abstract]   [Full Text] [Related]  

  • 56. Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis.
    Mehraban F; Seyedarabi A; Ahmadian S; Mirzaaghaei V; Moosavi-Movahedi AA
    J Transl Med; 2019 Jul; 17(1):227. PubMed ID: 31311548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The toxicosis parameters in children with different diseases].
    Sheĭman BS
    Lik Sprava; 2000; (5):56-60. PubMed ID: 11031452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Complex approach to the treatment of suppurative lesions of the foot in patients with diabetes mellitus].
    Dekhtiar' AL; Antsyshovich EA; Kalyshev IuG; Gorin VV; Pilipeev IG
    Klin Khir; 1995; (7-8):39-40. PubMed ID: 8624938
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of radiotherapy in the complex treatment of patients with complicated forms of diabetic angiopathy].
    Chaĭka OO
    Klin Khir; 1997; (9-10):27-8. PubMed ID: 9511320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Charcot foot: A historical complication of diabetes?].
    Reinhart F; Jochum G; Cordeanu M; Gaertner S; Miréa C; Stephan D
    Presse Med; 2015 Oct; 44(10):1089-91. PubMed ID: 26337360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.